Heat shock protein 90 ensures efficient mumps virus replication by assisting with viral polymerase complex formation

Journal of Virology

Volumn 91, Issue 6, 2017, Pages

  Katoh, Hiroshi ^a   Kubota, Toru ^a   Nakatsu, Yuichiro ^a   Tahara, Maino ^a   Kidokoro, Minoru ^a   Takeda, Makoto ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Heat shock protein 90; Large protein; Mumps virus; Polymerase

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; RNA DIRECTED RNA POLYMERASE; TANESPIMYCIN; UNCLASSIFIED DRUG; VIRAL L PROTEIN; VIRAL PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MUMPS VIRUS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA SYNTHESIS; VIRUS REPLICATION; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; MEASLES VIRUS; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MEASLES VIRUS; MUMPS VIRUS; PROTEIN STABILITY; PROTEOLYSIS; RNA REPLICASE; VIRUS REPLICATION;

EID: 85014091503     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02220-16     Document Type: Article

References (56)

1. Hviid A, Rubin S, Muhlemann K. 2008. Mumps. Lancet 371:932-944. https://doi.org/10.1016/S0140-6736(08)60419-5.
2. Lamb RA, Parks GD. 2006. Paramyxoviridae: the viruses and their replication, p 1449-1496. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Whelan SP, Barr JN, Wertz GW. 2004. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283:61-119.
4. Emerson SU, Wagner RR. 1973. L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. J Virol 12:1325-1335.
5. Hercyk N, Horikami SM, Moyer SA. 1988. The vesicular stomatitis virus L protein possesses the mRNA methyltransferase activities. Virology 163: 222-225. https://doi.org/10.1016/0042-6822(88)90253-X.
6. Hunt DM, Smith EF, Buckley DW. 1984. Aberrant polyadenylation by a vesicular stomatitis virus mutant is due to an altered L protein. J Virol 52:515-521.
7. Emerson SU, Schubert M. 1987. Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A 84:5655-5659. https://doi.org/10.1073/pnas.84.16.5655.
8. Kingston RL, Baase WA, Gay LS. 2004. Characterization of nucleocapsid binding by the measles virus and mumps virus phosphoproteins. J Virol 78:8630-8640. https://doi.org/10.1128/JVI.78.16.8630-8640.2004.
9. Cox R, Pickar A, Qiu S, Tsao J, Rodenburg C, Dokland T, Elson A, He B, Luo M. 2014. Structural studies on the authentic mumps virus nucleocapsid showing uncoiling by the phosphoprotein. Proc Natl Acad Sci U S A 111:15208-15213. https://doi.org/10.1073/pnas.1413268111.
10. Smallwood S, Ryan KW, Moyer SA. 1994. Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology 202:154-163. https://doi.org/10.1006/viro.1994.1331.
11. Chattopadhyay S, Banerjee AK. 2009. Phosphoprotein, P of human parainfluenza virus type 3 prevents self-association of RNA-dependent RNA polymerase, L. Virology 383:226-236. https://doi.org/10.1016/j.virol.2008.10.019.
12. Bloyet LM, Welsch J, Enchery F, Mathieu C, de Breyne S, Horvat B, Grigorov B, Gerlier D. 2016. HSP90 chaperoning in addition to phosphoprotein required for folding but not for supporting enzymatic activities of measles and Nipah virus L polymerases. J Virol 90:6642-6656. https://doi.org/10.1128/JVI.00602-16.
13. Masters PS, Banerjee AK. 1988. Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol 62:2658-2664.
14. Yabukarski F, Lawrence P, Tarbouriech N, Bourhis JM, Delaforge E, Jensen MR, Ruigrok RW, Blackledge M, Volchkov V, Jamin M. 2014. Structure of Nipah virus unassembled nucleoprotein in complex with its viral chaperone. Nat Struct Mol Biol 21:754-759. https://doi.org/10.1038/nsmb.2868.
15. Moyer SA, Baker SC, Lessard JL. 1986. Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci U S A 83:5405-5409. https://doi.org/10.1073/pnas.83.15.5405.
16. Bose S, Banerjee AK. 2004. Beta-catenin associates with human parainfluenza virus type 3 ribonucleoprotein complex and activates transcription of viral genome RNA in vitro. Gene Expr 11:241-249.
17. Ito M, Iwasaki M, Takeda M, Nakamura T, Yanagi Y, Ohno S. 2013. Measles virus nonstructural C protein modulates viral RNA polymerase activity by interacting with host protein SHCBP1. J Virol 87:9633-9642. https://doi.org/10.1128/JVI.00714-13.
18. Taipale M, Jarosz DF, Lindquist S. 2010. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515-528. https://doi.org/10.1038/nrm2918.
19. Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI, Lindquist S. 2012. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 150:987-1001. https://doi.org/10.1016/j.cell.2012.06.047.
20. Kirschke E, Goswami D, Southworth D, Griffin PR, Agard DA. 2014. Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. Cell 157:1685-1697. https://doi.org/10.1016/j.cell.2014.04.038.
21. Morishima Y, Murphy PJ, Li DP, Sanchez ER, Pratt WB. 2000. Stepwise assembly of a glucocorticoid receptor · hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocket. J Biol Chem 275: 18054-18060. https://doi.org/10.1074/jbc.M000434200.
22. Chen S, Prapapanich V, Rimerman RA, Honore B, Smith DF. 1996. Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70. Mol Endocrinol 10:682-693. https://doi.org/10.1210/mend.10.6.8776728.
23. Dittmar KD, Demady DR, Stancato LF, Krishna P, Pratt WB. 1997. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor·hsp90 heterocomplexes formed by hsp90 · p60 · hsp70. J Biol Chem 272:21213-21220.
24. Kundrat L, Regan L. 2010. Balance between folding and degradation for Hsp90-dependent client proteins: a key role for CHIP. Biochemistry 49:7428-7438. https://doi.org/10.1021/bi100386w.
25. Geller R, Taguwa S, Frydman J. 2012. Broad action of Hsp90 as a host chaperone required for viral replication. Biochim Biophys Acta 1823: 698-706. https://doi.org/10.1016/j.bbamcr.2011.11.007.
26. Geller R, Vignuzzi M, Andino R, Frydman J. 2007. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev 21:195-205. https://doi.org/10.1101/gad.1505307.
27. Burch AD, Weller SK. 2005. Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J Virol 79:10740-10749. https://doi.org/10.1128/JVI.79.16.10740-10749.2005.
28. Hu J, Toft DO, Seeger C. 1997. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J 16:59-68. https://doi.org/10.1093/emboj/16.1.59.
29. Hu J, Anselmo D. 2000. In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90. J Virol 74:11447-11455. https://doi.org/10.1128/JVI.74.24.11447-11455.2000.
30. Waxman L, Whitney M, Pollok BA, Kuo LC, Darke PL. 2001. Host cell factor requirement for hepatitis C virus enzyme maturation. Proc Natl Acad Sci U S A 98:13931-13935. https://doi.org/10.1073/pnas.241510898.
31. Naito T, Momose F, Kawaguchi A, Nagata K. 2007. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J Virol 81:1339-1349. https://doi.org/10.1128/JVI.01917-06.
32. Chase G, Deng T, Fodor E, Leung BW, Mayer D, Schwemmle M, Brownlee G. 2008. Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology 377:431-439. https://doi.org/10.1016/j.virol.2008.04.040.
33. Connor JH, McKenzie MO, Parks GD, Lyles DS. 2007. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses. Virology 362:109-119. https://doi.org/10.1016/j.virol.2006.12.026.
34. Geller R, Andino R, Frydman J. 2013. Hsp90 inhibitors exhibit resistancefree antiviral activity against respiratory syncytial virus. PLoS One 8:e56762. https://doi.org/10.1371/journal.pone.0056762.
35. Munday DC, Wu W, Smith N, Fix J, Noton SL, Galloux M, Touzelet O, Armstrong SD, Dawson JM, Aljabr W, Easton AJ, Rameix-Welti MA, de Oliveira AP, Simabuco FM, Ventura AM, Hughes DJ, Barr JN, Fearns R, Digard P, Eleouet JF, Hiscox JA. 2015. Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis. J Virol 89:917-930. https://doi.org/10.1128/JVI.01783-14.
36. Smith DR, McCarthy S, Chrovian A, Olinger G, Stossel A, Geisbert TW, Hensley LE, Connor JH. 2010. Inhibition of heat-shock protein 90 reduces Ebola virus replication. Antiviral Res 87:187-194. https://doi.org/10.1016/j.antiviral.2010.04.015.
37. Isaacs JS, Xu W, Neckers L. 2003. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3:213-217. https://doi.org/10.1016/S1535-6108(03)00029-1.
38. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, Patterson C. 1999. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19:4535-4545. https://doi.org/10.1128/MCB.19.6.4535.
39. Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L. 2002. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc Natl Acad Sci U S A 99:12847-12852. https://doi.org/10.1073/pnas.202365899.
40. Powers MV, Clarke PA, Workman P. 2008. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 14:250-262. https://doi.org/10.1016/j.ccr.2008.08.002.
41. Massey AJ, Williamson DS, Browne H, Murray JB, Dokurno P, Shaw T, Macias AT, Daniels Z, Geoffroy S, Dopson M, Lavan P, Matassova N, Francis GL, Graham CJ, Parsons R, Wang Y, Padfield A, Comer M, Drysdale MJ, Wood M. 2010. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother Pharmacol 66:535-545. https://doi.org/10.1007/s00280-009-1194-3.
42. Citri A, Alroy I, Lavi S, Rubin C, Xu W, Grammatikakis N, Patterson C, Neckers L, Fry DW, Yarden Y. 2002. Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy. EMBO J 21:2407-2417. https://doi.org/10.1093/emboj/21.10.2407.
43. Cyr DM, Hohfeld J, Patterson C. 2002. Protein quality control: U-boxcontaining E3 ubiquitin ligases join the fold. Trends Biochem Sci 27: 368-375. https://doi.org/10.1016/S0968-0004(02)02125-4.
44. Vaughan CK, Gohlke U, Sobott F, Good VM, Ali MM, Prodromou C, Robinson CV, Saibil HR, Pearl LH. 2006. Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell 23:697-707. https://doi.org/10.1016/j.molcel.2006.07.016.
45. Carsillo T, Zhang X, Vasconcelos D, Niewiesk S, Oglesbee M. 2006. A single codon in the nucleocapsid protein C terminus contributes to in vitro and in vivo fitness of Edmonston measles virus. J Virol 80: 2904-2912. https://doi.org/10.1128/JVI.80.6.2904-2912.2006.
46. Oglesbee MJ, Liu Z, Kenney H, Brooks CL. 1996. The highly inducible member of the 70 kDa family of heat shock proteins increases canine distemper virus polymerase activity. J Gen Virol 77:2125-2135. https://doi.org/10.1099/0022-1317-77-9-2125.
47. Katoh H, Kubota T, Kita S, Nakatsu Y, Aoki N, Mori Y, Maenaka K, Takeda M, Kidokoro M. 2015. Heat shock protein 70 regulates degradation of the mumps virus phosphoprotein via the ubiquitin-proteasome pathway. J Virol 89:3188-3199. https://doi.org/10.1128/JVI.03343-14.
48. Oliveira AP, Simabuco FM, Tamura RE, Guerrero MC, Ribeiro PG, Libermann TA, Zerbini LF, Ventura AM. 2013. Human respiratory syncytial virus N, P and M protein interactions in HEK-293T cells. Virus Res 177:108-112. https://doi.org/10.1016/j.virusres.2013.07.010.
49. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75:4399-4401. https://doi.org/10.1128/JVI.75.9.4399-4401.2001.
50. Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, Minamoto N. 2003. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 47: 613-617. https://doi.org/10.1111/j.1348-0421.2003.tb03424.x.
51. Saito H, Takahashi Y, Harata S, Tanaka K, Sano T, Suto T, Yamada A, Yamazaki S, Morita M. 1996. Isolation and characterization of mumps virus strains in a mumps outbreak with a high incidence of aseptic meningitis. Microbiol Immunol 40:271-275. https://doi.org/10.1111/j.1348-0421.1996.tb03346.x.
52. Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y. 2002. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76:6743-6749. https://doi.org/10.1128/JVI.76.13.6743-6749.2002.
53. Komase K, Nakayama T, Iijima M, Miki K, Kawanishi R, Uejima H. 2006. The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype. Vaccine 24:826-834. https://doi.org/10.1016/j.vaccine.2005.06.036.
54. Katoh H, Kubota T, Ihara T, Maeda K, Takeda M, Kidokoro M. 2016. Cross-neutralization between human and African bat mumps viruses. Emerg Infect Dis 22:703-706. https://doi.org/10.3201/eid2204.151116.
55. Takeuchi K, Tanabayashi K, Hishiyama M, Yamada YK, Yamada A, Sugiura A. 1990. Detection and characterization of mumps virus V protein. Virology 178:247-253. https://doi.org/10.1016/0042-6822(90)90400-L.
56. Lee JH, Khadka P, Baek SH, Chung IK. 2010. CHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activity. J Biol Chem 285:42033-42045. https://doi.org/10.1074/jbc.M110.149831.